1. Home
  2. West Africa
  3. Nigeria
  • News

Assemblymen want US grant spent on HIV/AIDS research

Nigeria’s House of Representatives has asked President Olusegun Obasanjo’s government to use, immediately, the US $10-million grant for HIV/AIDS made by President Bill Clinton, during his visit in August, to equip research laboratories on the disease in the country.

A report published by the Nigerian ‘Thisday’ newspaper on Sunday said the recommendation was part of the report of the House Committee on Health, following public hearings it conducted on claims by several Nigerians to have found drugs and vaccines that were effective against both the virus and the disease.

The daily said the report also called for “guidelines on procedures and mechanisms for scientific verification and evaluation to be made available to all concerned as a matter of urgency”.


This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

Share this article

Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

Become a member of The New Humanitarian

Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

Join